Melanoma/Skin Cancer News

Adults aged over 65 years who took thiazides for hypertension had an increased risk for keratinocyte carcinoma and melanoma, according to results of a population-based cohort study.

Tebentafusp significantly prolonged OS compared with immune checkpoint inhibitors and other standard therapies among previously untreated patients with metastatic uveal melanoma, results of a randomized phase 3 study showed.

Going through cancer during transitional adolescent and young adult years can present additional social, financial and mental health challenges that add to the stressors of diagnosis and treatment.

Early-stage invasive melanoma excised with Mohs micrographic surgery at academic and top decile-volume facilities was associated with improved long-term survival, according to a study published in JAMA Dermatology.

Diagnosis with actinic keratosis at age younger than 49 years or older than 80 years was associated with elevated cutaneous squamous cell carcinoma risk, according to a study.

Among patients with localized Merkel cell carcinoma, surgical margins larger than 1 cm improved survival regardless of factors such as tumor subsite and receipt of adjuvant chemotherapy, according to a study.

A large-scale surveillance program may allow clinicians to detect melanomas earlier in high-risk patients, according to a study.

Chronic immune-related adverse events appeared more common than previously thought among patients with stage III to stage IV melanoma who received adjuvant anti-PD-1 therapy, according to study results published in JAMA Oncology.

A trial designed to evaluate the addition of relatlimab to nivolumab for untreated metastatic or unresectable melanoma met its primary endpoint of improved PFS, according to topline data released by the agent’s manufacturer.

Tumor mutational burden predicted immunotherapy response for some, but not all, cancer types, according to study results published in Annals of Oncology.